Purevax RCP FeLV Uniunea Europeană - română - EMA (European Medicines Agency)

purevax rcp felv

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97) - produsele imunologice pentru felidae, - pisici - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs ;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease. onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component. the duration of immunity is one year after the last re-vaccination for the feline leukaemia component, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.

Purevax RCPCh Uniunea Europeană - română - EMA (European Medicines Agency)

purevax rcpch

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated chlamydophila felis (905 strain), attenuated feline panleucopenia virus (pli iv) - produsele imunologice pentru felidae, - pisici - active immunisation of cats aged eight weeks and older:• against feline viral rhinotracheitis to reduce clinical signs;• against calicivirus infection to reduce clinical signs;• against chlamydophila felis infection to reduce clinical signs;• against feline panleucopenia to prevent mortality and clinical signs. incidența imunității a fost demonstrată la o săptămână după vaccinarea primară pentru rinotraheită, calicivirus, chlamydophila felis și componentele panleucopeniei. the duration of immunity is one year after the last re-vaccination for the chlamydiosis component, and oneyear after primary vaccination and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.

Purevax RCPCh FeLV Uniunea Europeană - română - EMA (European Medicines Agency)

purevax rcpch felv

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97), attenuated chlamydophila felis (905 strain) - produsele imunologice pentru felidae, - pisici - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs;against chlamydophila felis infection to reduce clinical signs;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease. onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus, chlamydophila felis and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component. the duration of immunity is one year after the last re-vaccination for the chlamydiosis and feline leukaemia components, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.

Purevax RC Uniunea Europeană - română - EMA (European Medicines Agency)

purevax rc

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains) - produsele imunologice pentru felidae, - pisici - active immunisation of cats aged eight weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs. onsets of immunity isone week after primary vaccination course. the duration of immunity is one year after primary vaccination course and three years after the last re-vaccination.

Purevax RCCh Uniunea Europeană - română - EMA (European Medicines Agency)

purevax rcch

merial - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated chlamydophila felis (905 strain) - produsele imunologice pentru felidae, - pisici - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs and excretion;against chlamydophila felis infection to reduce clinical signs. incidența imunității a fost demonstrată la o săptămână după vaccinarea primară pentru rinotraheită, calicivirus și componente chlamydophila felis. durata imunității este de 1 an după ultima (re) vaccinare.

Fevaxyn Pentofel Uniunea Europeană - română - EMA (European Medicines Agency)

fevaxyn pentofel

zoetis belgium sa  - inactivated feline rhinotracheitis virus, inactivated feline calicivirus, inactivated feline chlamydophila felis, inactivated feline leukaemia virus, inactivated feline panleukopenia virus - immunologicals - pisici - pentru imunizarea activă a pisicilor sănătoase nouă săptămâni sau mai mari împotriva panleucopeniei feline și leucemiei feline viruși și împotriva bolilor respiratorii cauzate de virusul rinotraheitei feline, calicivirusul felin și chlamydophila felis.

Infectious Bovine Rhinotracheitis Virus (BHV1) gB Antibody Test Kit (IDEXX IBR gB X3) România - română - ICBMV (Institutul pentru Controlul Produselor Biologice si Medicamentelor de Uz Veterinar)

infectious bovine rhinotracheitis virus (bhv1) gb antibody test kit (idexx ibr gb x3)

mediclim srl, românia - set de diagnostic - reagenti. seturi de diagnostic - bovine - detecţia anticorpilor anti virusul rinotraheitei infectioase bovine în probe de ser, plasmă și lapte.

Bovine Rhinotracheitis Virus (BHV-1) gE Antibody Test Kit (IDEXX IBR gE) România - română - ICBMV (Institutul pentru Controlul Produselor Biologice si Medicamentelor de Uz Veterinar)

bovine rhinotracheitis virus (bhv-1) ge antibody test kit (idexx ibr ge)

mediclim srl, românia - set de diagnostic - reagenti. seturi de diagnostic - bovine - bovine detecţia anticorpilor anti virusul rinotraheitei infectioase bovine in probe de ser, plasma si lapte.

Infectious Bovine Rhinotracheitis Virus (BHV1) gB Antibody Test Kit (IDEXX IBR gB X3) România - română - ICBMV (Institutul pentru Controlul Produselor Biologice si Medicamentelor de Uz Veterinar)

infectious bovine rhinotracheitis virus (bhv1) gb antibody test kit (idexx ibr gb x3)

mediclim srl, românia - set de diagnostic - reagenti. seturi de diagnostic - bovine - detecţia anticorpilor anti virusul rinotraheitei infectioase bovine în probe de ser, plasmă și lapte.

Bovine Rhinotracheitis Virus (BHV-1) gE Antibody Test Kit (IDEXX IBR gE) România - română - ICBMV (Institutul pentru Controlul Produselor Biologice si Medicamentelor de Uz Veterinar)

bovine rhinotracheitis virus (bhv-1) ge antibody test kit (idexx ibr ge)

mediclim srl, românia - set de diagnostic - reagenti. seturi de diagnostic - bovine - bovine detecţia anticorpilor anti virusul rinotraheitei infectioase bovine in probe de ser, plasma si lapte.